PDI has debuted the Prevantics ® Device Swab, a chlorhexidine gluconate/alcohol solution that has received market authorization from the U.S. Food and Drug Administration for disinfecting needleless ...
Investigators have released results from the first, randomized, crossover, prospective, comparative effectiveness clinical study evaluating the benefits of a 3.15% Chlorhexidine Gluconate and 70% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results